Partner With Us
Partnering refers to the process of enabling one or more services to provide secure communication and collaboration between the Company and its external business partners.
EngageZone provides a secure and highly compartmentalized collaborative work environment for the Company and its worldwide business partners to exchange documents and to facilitate communications. Partners signing into EngageZone have controlled access and visibility to all their collaborations that use EngageZone in one place, regardless of which company business units they are working with.
Bringing together the most promising external early discovery research with our substantial R&D capabilities to validate and advance emerging therapeutic targets, pathways and technologies that show potential relevance to treat human disease.
The Innovation Network is an ongoing effort to seek beneficial collaborations with researchers that will advance the most innovative discoveries for therapeutic targets, pathways and technologies. Since launching in 2012, more than 40 MINt collaborations and ongoing projects have been established, underscoring the importance of industry and academic interactions in the early discovery space.
The Company Investigator Studies Program is open to all academic and community-based physicians and researchers worldwide who are interested in conducting their own research. This program consists of committees of medical and scientific staff from different therapeutic areas who meet regularly to review our company's investigator study proposals. Support is provided based on the scientific merit of the proposal as well as whether it is in alignment with the published areas of interest. Information related to areas of interest and requirements for submission can be found by clicking on the appropriate link for your therapeutic area.
The Company is fully committed to providing qualified scientific researchers access to anonymized patient level data and full clinical study reports (CSRs) from our clinical trials. Qualified researchers with appropriate competencies, engaged in rigorous, independent scientific research can submit a data request for patient-level data or a full CSR.
The Company will provide access to patient-level data and CSRs for clinical trials performed by the Company for which results are posted on the clinicaltrials.gov registry (dating back to September 2007) for products or indications that have been approved by regulators in the US and EU. In general, data will be made available for request approximately 18 months after clinical trial completion and acceptance of a primary results manuscript. Data from Phase I trials in healthy volunteers and consumer health care studies are out of scope.